LncRNAs in tumor microenvironment: The potential target for cancer treatment with natural compounds and chemical drugs

Biochem Pharmacol. 2021 Nov:193:114802. doi: 10.1016/j.bcp.2021.114802. Epub 2021 Oct 19.

Abstract

It was thought that originally long non-coding RNAs (lncRNAs) were a kind of RNAs without any encoding function. Recently, a variety of studies have shown that lncRNAs play important roles in many life activities. The abnormal expression of lncRNAs in tumor microenvironment (TME) usually promotes the proliferation, migration, and drug resistance of tumor cells through direct or indirect effects, which also usually predicts the poor prognosis. The regulation of lncRNAs expression in TME could significantly inhibit tumor progress. However, the interaction between lncRNAs and TME has not been fully defined at present. Therefore, this paper provided the systemic summary of their interaction and natural products and chemicals targeting lncRNAs in cancer treatment. Currently, the strategies of cancer treatment still have their limits. Understanding the relationship between TME and lncRNAs can help us to realize breakthrough strategy for tumor treatment.

Keywords: Drug; LncRNAs; Stromal cells; Tumor; Tumor microenvironment (TME).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biological Products / therapeutic use*
  • Drug Delivery Systems*
  • Drug Development
  • Humans
  • Neoplasms / drug therapy*
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*

Substances

  • Antineoplastic Agents
  • Biological Products
  • RNA, Long Noncoding